A 31-year-old man came to an outpatient university-based clinic with a 1-week history of new-onset skin lesions in his axillae. The patient\'s medical history was remarkable for neurofibromatosis type 1 and glioblastoma multiforme of the left cerebellum. After surgical resection of his cerebellar tumor, his treatment regimen included bevacizumab, dexamethasone, levetiracetam, pembrolizumab, and trametinib. Examination showed full-thickness dermal loss in bilateral axillae, with affected areas confined to longstanding striae ([Figs 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). There was no significant surrounding erythema, and no accompanying drainage or purulence. No mucosal involvement was present.Figure 1by H. Harris Reynolds, MD and Lauren C. S. Kole, MDFigure 2by H. Harris Reynolds, MD and Lauren C. S. Kole, MD

**What is the most likely diagnosis?**A.Pyoderma gangrenosumB.Necrobiotic XanthogranulomaC.Medication-induced ulcerationD.Extragenital lichen sclerosusE.Necrobiosis lipoidica

Click [here](https://digital-catalog.aad.org/diweb/catalog/launch/package/4/did/434979/iid/434979){#intref0010} to view disclosures, take the quiz, and claim CME credit.
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